Research status of GLP-1 receptor agonists in the treatment of obesity
10.13406/j.cnki.cyxb.003722
- VernacularTitle:GLP-1受体激动剂类药物在肥胖治疗中的研究现状
- Author:
Yacong ZHAO
1
;
Chen WANG
;
Jianzhong DI
Author Information
1. 上海交通大学医学院附属第六人民医院减重代谢外科,上海 200233
- Keywords:
glucagon-like peptide-1 receptor agonists;
type 2 diabetes;
obesity;
body weight
- From:
Journal of Chongqing Medical University
2025;50(8):1011-1015
- CountryChina
- Language:Chinese
-
Abstract:
As a chronic and complex disease,obesity can cause many other diseases.Obesity is influenced by many factors.At present,the main treatment methods for obesity are behavioral intervention,medication,endoscopic therapy,and sleeve gastrectomy.New break-throughs and progress have achieved in medication.This article mainly introduces the latest clinical situation and adverse reactions of several representative drugs in glucagon-like peptide-1 receptor agonists,such as liraglutide,semaglutide,and tirzepatide.This article mainly aims to analyze the safety and efficacy of these anti-obesity drugs and provide guidance for future clinical medication.
